GB1502573A - Somatostatin analogues - Google Patents

Somatostatin analogues

Info

Publication number
GB1502573A
GB1502573A GB32268/76A GB3226876A GB1502573A GB 1502573 A GB1502573 A GB 1502573A GB 32268/76 A GB32268/76 A GB 32268/76A GB 3226876 A GB3226876 A GB 3226876A GB 1502573 A GB1502573 A GB 1502573A
Authority
GB
United Kingdom
Prior art keywords
peptides
somatostatin
analogues
somatostatin analogues
isonicotinoyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB32268/76A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of GB1502573A publication Critical patent/GB1502573A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB32268/76A 1975-08-08 1976-08-03 Somatostatin analogues Expired GB1502573A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60306775A 1975-08-08 1975-08-08
US68000576A 1976-04-23 1976-04-23

Publications (1)

Publication Number Publication Date
GB1502573A true GB1502573A (en) 1978-03-01

Family

ID=27084324

Family Applications (1)

Application Number Title Priority Date Filing Date
GB32268/76A Expired GB1502573A (en) 1975-08-08 1976-08-03 Somatostatin analogues

Country Status (8)

Country Link
JP (1) JPS5219659A (cg-RX-API-DMAC7.html)
CH (1) CH626328A5 (cg-RX-API-DMAC7.html)
DE (1) DE2635558A1 (cg-RX-API-DMAC7.html)
DK (1) DK328876A (cg-RX-API-DMAC7.html)
FR (1) FR2320109A1 (cg-RX-API-DMAC7.html)
GB (1) GB1502573A (cg-RX-API-DMAC7.html)
NL (1) NL7607987A (cg-RX-API-DMAC7.html)
SE (1) SE419440B (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7126001B2 (en) 1999-09-08 2006-10-24 Sloan-Kettering Institute For Cancer Research Class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115554A (en) * 1977-08-29 1978-09-19 Merck & Co., Inc. Somatostatin analogs
LU78191A1 (de) * 1977-09-28 1979-05-25 Ciba Geigy Ag Verfahren zur herstellung von neuen cyclopeptiden
US4139526A (en) * 1977-12-01 1979-02-13 Merck & Co., Inc. Somatostatin analogs
US4140767A (en) * 1977-12-01 1979-02-20 Merck & Co., Inc. Somatostatin analogs
JPS5819669B2 (ja) * 1978-10-28 1983-04-19 白井松新薬株式会社 新規生理活性ペプチド化合物及びその製造法
US4316890A (en) * 1979-03-16 1982-02-23 Ciba-Geigy Corporation Peptides and processes for the manufacture thereof
US4244947A (en) * 1979-08-13 1981-01-13 Ayerst Mckenna And Harrison Inc. Carba decapeptide derivatives of [TYR6 ]-somatostatin
NL8701143A (nl) * 1986-05-27 1987-12-16 Sandoz Ag Farmaceutische preparaten.
US5443815A (en) * 1991-11-27 1995-08-22 Diatech, Inc. Technetium-99m labeled peptides for imaging
AU664855B2 (en) * 1991-08-09 1995-12-07 Winfried Kolbeck Lanthionine bridged peptides
US6017512A (en) * 1992-06-23 2000-01-25 Diatide, Inc. Radiolabeled peptides
US5716596A (en) * 1992-06-23 1998-02-10 Diatide, Inc. Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses
US5620675A (en) 1992-06-23 1997-04-15 Diatech, Inc. Radioactive peptides
AT401517B (de) * 1993-08-20 1996-09-25 Hafslund Nycomed Pharma Asymmetrisch substituierte diaminodicarbonsäurederivate und ein verfahren zu deren herstellung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6509712A (cg-RX-API-DMAC7.html) * 1964-07-27 1966-01-28
DE2460469A1 (de) * 1974-12-20 1976-07-01 Hoechst Ag Neue peptide mit biologischer wirkung und verfahren zu ihrer herstellung

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7126001B2 (en) 1999-09-08 2006-10-24 Sloan-Kettering Institute For Cancer Research Class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
US7345174B2 (en) 1999-09-08 2008-03-18 Sloan-Kettering Institute For Cancer Research Cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof

Also Published As

Publication number Publication date
JPS5219659A (en) 1977-02-15
NL7607987A (nl) 1977-02-10
FR2320109A1 (fr) 1977-03-04
SE7608300L (sv) 1977-02-09
DK328876A (da) 1977-02-09
SE419440B (sv) 1981-08-03
CH626328A5 (en) 1981-11-13
DE2635558A1 (de) 1977-02-17
FR2320109B1 (cg-RX-API-DMAC7.html) 1979-05-25

Similar Documents

Publication Publication Date Title
BE848712A (fr) Compositions d'acides carboxyliques,
BE820253A (fr) Esters d'amino acides
GB1548553A (en) Addition compound of dipeptide derivative and amino acid derivative
EP0711305A4 (en) PROTEGRINE
PH12100A (en) Olefinic derivatives of amino acids
DK270278A (da) Cycliske aminosyrer
FR2299023A1 (fr) Compositions d'aminoacides
ATE121755T1 (de) Deletionsanaloga von magaininpeptiden.
ES2081817T3 (es) Polipeptido con secuencias principales repetidas que se fijan en la celula.
DE69012901D1 (de) Hämoregulierende Peptide.
AU526356B2 (en) Amino acid intermediates for the preparation of prosta- glandin analogues
FR2320109A1 (fr) Analogues de somatostatine
NL7807087A (nl) Alpha-acetyleenderivaten van alpha-aminozuren.
BE855135A (fr) Produits cosmetiques contenant des n-hydroxyalkylamides d'acides alcanoiques comme agents hydratants de la peau
IL42787A0 (en) Composition and method for promotion of protein synthesis and suppression of urea formation in the body utilizing hydroxy-acid analogs of amino acids
ES481785A1 (es) Procedimiento de preparacion de compuestos del tipo muramil-dipeptido.
GB2001056B (en) -acetylene and -vinyl derivative of amino acids
FI870811A7 (fi) Pentapeptider med en cellvaextreglerande effekt och ett foerfarande foer framstaellning av desamma.
IT1068443B (it) Procedimento di preparazione dell'alfa ammino gamma metilmercaptobutirronitrile
JPS5436262A (en) Alphaahalomethyl derivative of amino acid
DE2965364D1 (en) Alpha-difluoromethyl amino acids and pharmaceutical composition containing the same
BE830545A (fr) Triazinesulfenimides derivees d'acides dicarboxyliques
IL47401A (en) Herbicidal compositions containing chlorophenoxy-phenoxy propionic acids or esters thereof and(3-methoxycarbonylamino) phenyl n-(3'-methylphenyl)carbamate
SE8200757L (sv) Biologiskt aktiva peptider
IT1058773B (it) Procedimento per la preparazione di alfa amminoacidi

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee